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Abstract. The scope of carbon monoxide-free Asymmetric 
Transfer HydroFormylation (ATHF) procedures using a 
highly active single catalyst system derived from 1,2-bis-
((2,5)-diphenylphospholano)ethane as chiral ligand has been 
studied. This  reveals some highly successful reactions, but 
also significant limitations. The development of a new 
protocol in which a catalyst for formaldehyde decomposition 
to CO and H2  is combined with the catalyst of choice for the 
subsequent asymmetric hydroformylation is described.  This 
enables ATHF reactions that were problematic to be 
significantly improved. The new method has been used in 
the synthesis of several key precursors to biologically active 
molecules. 
Keywords: Hydroformylation; Asymmetric Synthesis; 
Carbon monoxide surrogates; Regioselectivity; Rhodium 
 
Introduction 
There is no argument that the ‘conventional’ rhodium 
catalysed hydroformylation reaction is a valuable 
reaction; several examples are practised at huge scale 
for commodity and fine chemicals.[1] While 
recognised as a tool in organic synthesis,[1] it is 
perhaps underused in research-scale organic synthesis. 
One reason for this could be the initial nervousness of 
the non-expert in using CO gas, and the requirement 
to invest in some equipment to operate the reactions. 
For this reason, improved protocols for various types 
of CO-free hydroformylations are needed urgently. 
Some particularly desirable carbon monoxide 
surrogates are easily transportable and are available 
from waste biomass (e.g. formaldehyde, methanol, 
oxalates, formates etc.). It is therefore also 
conceivable that some larger scale hydroformylation 
could one day be operated using a CO surrogate 
should such methods be competitive with the use of 
syngas. The use of formaldehyde as a surrogate for 
both CO and hydrogen is highly appealing and has 
been the topic of research for some time.[2-5] Probably 
the seminal work in this arena was by Morimoto and 
co-workers who discovered that a dual catalyst 
system could be used to conduct linear selective 
hydroformylations of alkenes using formaldehyde as 
CO source.[3] More recently, our group and the 
Morimoto group reported in 2015 that 
enantioselective hydroformylation can be carried out  
using formaldehyde as a surrogate for syngas.[4,5] 
These Asymmetric Transfer Hydroformylations are  
given the acronym ATHF, since AHF is sometimes 
used to refer to Asymmetric HydroFormylations.  
Labelling studies by both groups came to the same 
conclusion; that the ATHF is a transfer 
hydroformylation from a practical point of view, but 
mechanistically a tandem process in which the 
catalyst is adept at both decomposition of 
formaldehyde to syngas, and a highly reactive 
catalyst for low-pressure hydroformylation. 
 
Both research studies relied on the use of the same 
ligand, Ph-BPE (1) (Fig. 1),[6] combined with 
different Rh sources: [Rh(acac)(CO)2][4] or 
[{RhCl(cod)}2].[5] In order to fully appreciate the 
rarity of catalysts that can conduct the two steps of 
formaldehyde decomposition and hydroformylation 
in ATHF, Fig 1 shows the best conversion to 
aldehydes found for some well established 
hydroformylation ligands in this first phase of work. 
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Figure 1. Ligands used in this study, and conversion to 
aldehyde obtained in the transfer hydroformylation of cis-
stilbene using 1 mol% Rh catalysts, 3 mol% ligand, 6 
equivalents of paraformaldehyde, at 120 oC for 45 minutes, 
as communicated in ref. 4. Toluene was used as solvent, 
and in those unsuccessful reactions significant amount of 
trans-stilbene were detected (see ref 4). 
There are several reasons for the very low yields of 
aldehyde product for all of the catalysts except those 
derived from Ph-BPE: some catalysts might not 
survive the relatively high temperatures, or could lead 
to extensive isomerisation before hydroformylation 
takes place. Some catalysts might not operative well 
at the relatively low pressures of syngas generated, 
and/or some catalysts might not be able to produce 
sufficient syngas to operate properly. The substrate 
chosen was quite a poorly reactive alkene. It is 
difficult since one of the rate-determining parts of a 
conventional hydroformylation is the exchange of a 
CO ligand for an alkene. Anything other than a 1-
alkene tends to compete less successfully with CO. In 
fact the results obtained with [Rh(acac)(CO)2] / Ph-
BPE on this less reactive alkene are quite remarkable 
since conventional hydroformylation using this 
catalyst after several attempts using normally optimal 
conditions did not give higher than 74% e.e. The 
ATHF therefore shows slightly different 
characteristics from conventional hydroformylation, 
probably as a result of the gradually produced low 
concentrations of CO being quite hard to achieve 
using a normal hydroformylation protocol in a sealed 
vessel. 
 
Scheme 1. ATHF of cis-stilbene using different Rh 
sources. 
 
Using the same Ph-BPE ligand and [RhCl(cod)2] 
instead of [Rh(acac)(CO)2] leads to almost no product 
(Scheme 1). The combination of [RhCl(cod)2] and 
Ph-BPE is an excellent catalyst for decomposition of 
formaldehyde: based on simple experiments, using 
the pressure sensor in a chemical microwave to 
measure pressure build up without alkene present, it 
is superior to [Rh(acac)(CO)2] / Ph-BPE. However, it 
seems likely that [RhCl(cod)2] and Ph-BPE only 
produce low levels of the most active 
hydroformylation catalyst, [RhH(CO)2(Ph-BPE)], or 
that this mixture converts to a less reactive 
hydroformylation catalyst of a different form.  With a 
highly reactive terminal alkene substrate, like styrene, 
used in reference 5, then this catalyst works 
especially well (and we have been able to reproduce a 
typical  protocol from reference 5 well). However, we 
had found that our most successful combination 
[Rh(acac)(CO)2] / Ph-BPE does not promote ATHF 
of styrene very well due to low regioselectivity. From 
this we infer that that our preferred catalyst produced 
CO and hydrogen at a slow rate relative to styrene 
hydroformylation; this can lead to linear selectivity in 
the hydroformylation of styrene.[7] However, for other 
alkenes, the use of [Rh(acac)(CO)2], which is more 
commonly used in conventional hydroformylation 
catalysis, is more reactive and can deliver high 
selectivity. 
In this paper we report on a project aimed at 
exploring the scope of the Rh/ Ph-BPE system, and 
the development of conditions that allow the use of 
other chiral hydroformylation ligands in a syngas-free 
ATHF procedure. We hope that, in addition to 
Ph Ph
1mol% [Rh(acac)(CO)2], 3 mol% Ligand
6 equiv. [CH2O]n, toluene 
120 oC, 45 mins.
Ph Ph
CHO
87
Ligand = (R,R)-1
80% product, (72% isolated), 95 % ee, (R)
[Rh(acac)(CO)2]
Ligand = (R,R)-1
2% product.
[Rh(m-Cl)(COD)]2
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providing useful catalytic methods for various targets, 
the findings should be enabling to other researchers 
who wish to develop a syngas-free hydroformylation 
reaction. 
Results and Discussion 
The [Rh(acac)(CO)2] / Ph-BPE catalyst was 
reported in our original communication to give high 
yields in the transfer hydroformylation of a range of 
alkenes, but probably the most striking results were 
the ATHF of cis-stilbene and a few derivatives. The 
scope of this catalyst was first studied on the ATHF 
of some asymmetrically substituted cis-stilbene 
derivatives. Despite some achievements,[8] there is a 
lack of predictability, and further research needed on 
the hydroformylation of non-symmetric alkenes in 
general.  
 
Scheme 2. The preparation of cis-stilbene derivatives 
used in this study. 
 
For this reaction, we studied this aspect using four 
carefully chosen alkenes (Scheme 2). A two-step 
methodology was used to make the substrates: a 
Sonogashira cross-coupling reaction[9] to give alkynes 
9-12, followed by a cis-selective reduction. The latter 
step required different methods depending on the 
alkynes used, with the planned Lindlar reduction 
being replaced by a Ti mediated[10] or a Pt 
catalysed[11] reduction adapted from the literature for 
15 and 16 respectively. The synthesis of these alkenes 
is discussed in more detail in the ESI, but alkenes 13-
18 were prepared in sufficient quantity and purity to 
carry out the studies discussed. 
 
Conventional hydroformylation of alkenes 13 -16 
with a catalyst derived from [Rh(acac)(CO)2] and  
1,3,5,7-tetramethyl-2,4,8-trioxa-6-
phosphaadamantane[12] was carried out. This gave a 
preliminary indication of the regioselectivity that 
these substrates might favour. These results are 
shown and discussed in more detail in the ESI; 
conversion and chemselectivity was good, and 
selectivities were around 2:1. The two regioisomers 
were found to be inseparable. The aldehydes were 
reduced with NaBH4 to an inseparable mix of the 
regioisomeric alcohols, which could be resolved by 
analytical chiral HPLC. The identity of the major and 
minor aldehyde (or alcohol) could be assigned 
through the use of 1H-13C HMBC NMR.  
 
Conventional asymmetric hydroformylation using 
syngas and chiral Rh catalysts was studied and is 
described in the ESI; despite many variations in 
conditions, AHF did not lead to promising results 
with these challenging substrates. The long reaction 
times necessary for AHF often led to full 
consumption of the starting material but also 
isomerisation to the (E)-alkene and low 
enantioselectivity. ATHF was studied next, which 
gave higher conversion, as described below. 
 The initial ATHF reactions were explored with 
alkene 13. The standardised conditions (120 °C, 1 h, 
[CH2O]n (6 eq.) observed 55% conversion to the 
aldehydes, with a 64:36 regioselectivity favouring 
aldehyde 17 with 41% e.e but 90% e.e for the minor 
component, 18 (Table 1, entry 1). The lower e.e. for 
17 is presumed to be a result of the more electron-
withdrawing aryl ring adjacent to the formyl group 
stabilising the enol tautomer, leading to racemisation 
under the reaction conditions. This decrease in 
selectivity (and conversion) is emphasised for longer 
reaction periods (Table 1, entry 2 & 3), despite using 
a lower temperature (Table 1, entry 2). This is 
consistent with the observation that slower AHF 
reactions were unsuccessful with these substrates. 
Larger amounts of the trans-alkene are also 
noticeable at long reaction times, but with no increase 
in aldehyde yield. The possibility of 
dehydroformylation of the aldehydes to the more 
stable (E)-isomer as the cause was disproved (see 
ESI). Therefore, an alternative explanation may relate 
to decomposition of the catalyst over time, meaning 
only the simpler process of alkene isomerisation is 
possible. As a longer reaction time had a negative 
impact on the selectivity, we shortened the reaction 
time to 30 minutes, which led to increase in 
conversion to the aldehydes (61%), regioselectivity 
(68:32) and enantioselectivity for 17 to 84% e.e. 
(Table 1, entry 4). The major regioisomer of the 
aldehyde, (17) forms adjacent to the electron-
withdrawing methyl-ester; this is possibly due to the 
stabilisation of the negative charge built up during C-
H bond formation by the electron poor arene. 
  
 
H
X
R1
R2
R2
R1
[PdCl2(PPh3)2] (4 mol %)
X = I, Br
piperidine, 80 °C, 1 h
+
9-12
(70-78% yield)
R1 R
2
cis-selective reduction
(see ESI)
MeO
O
13
MeO
14
O
OMe
OMe
MeO OMe
15
OMe
16
OMe
MeO
O
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Table 1. Asymmetric Transfer HydroFormylation of 
asymmetrically substituted Z-alkenes.  
 
 
ATHF of methyl (Z)-2-(4-methoxystyryl)benzoate, 
14, gave lower product yield, and favours aldehyde 
19 31%, 19:20 = 68:32). Both of these observations 
can be rationalised as being due to the sterically 
bulky ortho substituent hindering the coordination of 
the alkene to the metal centre. Enantioselectivity was 
excellent (Table 1, entry 5). ATHF of alkene 16 
obtained 65% conversion to the aldehydes and a 
65:35 regioselectivity favouring aldehyde 21. This 
regioselectivity again places the aldehyde away from 
an ortho substituent and also on the more electron 
deficient of the alkene carbons. Enantioselectivity 
was excellent: 95% e.e for the major isomer and 98% 
e.e for the minor isomer, reflecting good 
configuration stability (Table 1, entry 6). 
Table 2. Asymmetric Transfer Hydroformylation of alkene 
15.  
 
Hydroformylation of alkene 15 is a possible new 
route to (S)-Equol {(3S)-3-(4-hydroxyphenyl)-7-
chromanol}.[13] ATHF of alkene 15, gave relatively 
low conversion to the aldehydes (37%) using the 
standard conditions (120 °C, [CH2O]n (6 eq.), 1 h), as 
well as regioselectivity to the undesired regioisomer, 
24 as the major product (38:62). This was also 
observed with AHF using [Rh]/Ph-BPE (see ESI). 
This is hypothesised to be due to the lack of 
electronic or steric bias. However, enantioselectivity 
was excellent, achieving 98% e.e for the major 
(undesired) isomer and 95% for the minor (desired) 
(Table 2, entry 1). Using 4 equivalents of 
paraformaldehyde and increasing the reaction time, 
optimally to 4 hours, led to a higher conversion 
(85%) (Table 2, entry 4). The conventional AHF of 
alkene 15 using the [Rh]/Bisdiazaphos, 4 catalyst14 
led to good regioselectivity towards the desired 
regioisomer, 2 (see ESI), but conversion to the 
aldehydes never exceeded 40% (up to 14% isolated 
yield of alcohol). The good selectivity made transfer 
hydroformylation using this ligand of great interest, 
since we hoped the lower pressures of CO might 
improve reactivity, whilst retaining selectivity. The 
ATHF reaction was run at 120 °C for 4 hours and 
delivered 74:26 regioselectivity towards the desired 
Ar2
Ar1
[Rh(acac)(CO)2] (2 mol%)
Ph-BPE (3 mol%)
[CH2O]n (6 eq.), 120 °C
+
Ar2Ar1
CHO
Ar2Ar1
CHO
Entry Alkene t(h)
%
Aldehyde
[yield][a]
Regio-
selectivity
e.e.
major
e.e.
minor
1 55[37] 64:36 41 90
3[b] 8[6] 60:40 31 88
2 48[38] 65:35 38 89
0.5 61[43] 68:32 84 90[c]
1 31[27] 68:32 90 n.d.
1 65[35] 65:35 95 98
[a] Remaining mass balance is mainly E isomer of alkene, except final 2 
entries which are starting material.
% aldehyde determined by NMR spectroscopy against cyclooctane as 
internal standard. Isolated yield in square brackets are for the 
corresponding alcohols obtained after both hydroformylation and then 
NaBH4 reduction and chromatography (e.e. determined at this stage).
[b] 110 oC; [c] result reported in communication (ref. 4).
ratio: 17: 18
ratio: 19: 20
ratio: 21: 22
22
MeO
OMe
O
MeO
O
17
OMe20
O
MeO
OMe MeO
O
18 OMe
OMe19
O
MeO
21
MeO
OMe
O
CHO OHC
CHO OHC
CHO OHC
1 13
2 13
3 13
4 13
5 14
6 16
toluene
[Rh(acac)(CO)2] (2 mol%)
Ph-BPE (3 mol%)
[CH2O]n (6 eq.), 120 °C +
t(h)
%
Aldehyde
[yield][a]
23 : 24
e.e.
major
e.e.
minor
1 37[13] 38:62 98 95
2 47[27] 39:61 94 88
2 63[25] 42:58 91 88
4 85[30] 45:55 96 93
[a] Remaining mass balance is mainly starting material, except entry 2 
(15%) and entry 5 (57%) E isomer of alkene
% aldehyde determined by NMR spectroscopy against cyclooctane as 
internal standard. Isolated yield in square brackets are for the 
corresponding alcohols obtained after both hydroformylation and then 
NaBH4 reduction and chromatography (e.e. determined at this stage).
Ar2
OMe
Ar2
MeO
CHO
*
Ar2
MeO
*
OHC
OMe
OMe
Ar2 =
Entry (CH2O)n
(equiv.)
1 6
6
4
4
4 4 21[6] 76:24 88 92
2
3
4
5[b]
[b] Ligand 4 (Fig 1) used in place of (R,R)-Ph-BPE
15
23 24
toluene
10.1002/adsc.201900640
Ac
ce
pt
ed
 M
an
us
cr
ip
t
Advanced Synthesis & Catalysis
This article is protected by copyright. All rights reserved.
 5 
regioisomer, but gave low conversion and was 
accompanied by significant isomerisation to the (E)-
alkene (Table 2, entry 5). The low conversion was 
ascribed to Bisdiazaphos being a poor ligand for the 
decarbonylation of paraformaldehyde into syngas. 
 
This result highlights an issue with using a single 
ATHF catalyst: so few ligands are able to promote 
both the formaldehyde decomposition and 
hydroformylation reactions. As another example that 
illustrates this, branched selective hydroformylation 
of allyl benzene derivatives is of interest, but the Rh / 
Ph-BPE system has been reported to give low 
regioselectivity and low e.e. in AHF of this 
substrate.[15a] 
It would therefore be a step forward if the asymmetric 
transfer hydroformylation reaction could be 
developed to utilise a dual catalyst system, where the 
decarbonylating ability of Rh/ Ph-BPE could be 
combined with the selectivity of a different catalyst, 
in order to achieve optimum conversion and 
selectivity. 
 
 Table 3 Transfer hydroformylation of allyl benzene 
 
 
 
 
 
Allyl benzene was chosen as a challenging model 
substrate for our optimisation of this process, since 
isomerisation to the internal conjugated alkene, prop-
1-en-yl benzene is a downhill process. In addition, 
most catalysts give no selectivity or favour the linear 
aldehyde in hydroformylation of unbiased alkenes of 
this type, with the main exception being catalysts 
derived from ligand 2 that can give around 75-80% 
selectivity.[15] 
ATHF of allyl benzene was studied, with a dual 
catalyst system. Simply combining a Rh source with 
ligand 2 along with a better formaldehyde 
decomposition catalyst A, [RhCl(cod)2] and (S,S)-Ph-
BPE (Table 3, entry 1) was not effective. The key to 
getting improved results is the physical separation of 
the catalysts from the alkene inside a single vessel, 
allowing the decarbonylation reaction to generate 
syngas at high temperature, prior to mixing of the 
alkene with the hydroformylation catalyst after 
cooling to a lower temperature optimal for high 
selectivity. While such procedures are well-known 
functions that can be added to a commercial pressure 
reactor, a simple solution for laboratory scale 
procedures is described in the ESI and is what has 
been used here. This leads to an improvement from 
40% aldehydes and low selectivity (Table 3, entry 1) 
to high yield, b:l of 2.1:1 and 79% e.e. (Table 3 entry 
2). If catalyst B, derived from (Sax,S,S)-2 is used 
without an addition formaldehyde decomposition 
catalyst, then a low yield is observed (Table 3, entry 
3). As a control experiment, if both formaldehyde 
decomposition catalyst, A and hydroformylation 
catalyst B are derived from (S,S)-Ph-BPE, then the 
selectivity changes to favour the linear aldehyde 
slightly, along with producing some prop-1-en-yl 
benzene (Table 3, entry 4). The enantioselectivity 
was low, as was observed in previous work using 
syngas as reagent.[15a] It stands to reason that racemic 
Ph-BPE would be equally effective as the single 
enantiomer in the formaldehyde decomposition, but 
since this work was aimed at organic synthesis 
laboratories, we have only used the commercially 
available single enantiomer. Unfortunately, changing 
catalyst A to utilise the achiral ligand dppe (dppe = 
1,2-bis diphenylphosphinoethane), reduces yield 
(Table 3, entry 5, see ESI for some other examples). 
It is clear that catalyst B alone carries out the 
hydroformylation step, despite the presence of 
another Rh catalyst in the same solution, since the 
mix of catalyst B and achiral dppe-derived catalyst A 
in entry 5 gives similar enantioselectivity to that 
shown in entry 2. To further support this, if the 
enantiomer of ligand 2 in catalyst B is switched, 
while keeping the (S,S) enantiomer of Ph-BPE in 
catalyst A, similar enantioselectivity towards the 
opposite enantiomer of product is observed (Table 3, 
entry 6). In summary, while the normal conditions are 
not at all useful for an isomerisation prone substrate 
like allyl benzene, this dual catalyst system with the 
alkene mixed only after syngas has been generated 
leads to significantly improved results, if not 
matching optimised conditions using syngas; this was 
then examined on other substrates to see if it has 
general use. 
 
[a] % aldehyde determined by NMR spectroscopy against methyl 
naphthalene as internal standard. e.e. determined on the corresponding 
alcohol obtained after both hydroformylation and NaBH4 reduction.
[b] alkene, formaldehyde and pre-mixed catalyst solution all added prior 
to step (i).
[c] alkene only mixed with catalysts after step (i)
[d] 10% isomerised internal alkene detected
0.8% Catalyst A
[CH2O]n (5 eq.), toluene 
(i) 120 °C, 30 min; (ii) 40 oC, 16h
Ph
MePh
CHO
* Ph(CH2)3CHO
b l
2.1 % Catalyst B
Catalyst A Catalyst B Product 
(%)[a]
b:l e.e.
(%)
0.8% [RhCl(COD)]2 
0.9% (S,S)-Ph-BPE
2.1 % [Rh(acac)(CO)2] 
2.6 % (Sax,S,S)-2 40
[b] 55:45 27(1)
(2)
0.8% [RhCl(COD)]2 
0.9% (S,S)-Ph-BPE
2.1 % [Rh(acac)(CO)2] 
2.6 % (Sax,S,S)-2 96
[c] 69:31 79 (S)
(3)
2.1 % [Rh(acac)(CO)2] 
2.6 % (Sax,S,S)-2N/A 35
[c] 63:27 73 (S)
(4)
0.8% [RhCl(COD)]2 
0.9% (S,S)-Ph-BPE
2.1 % [Rh(acac)(CO)2] 
2.6 % (S,S)-Ph-BPE 69[c,d] 40:60 2 (S)
(5)
0.8% [RhCl(COD)]2 
0.9% dppe
2.1 % [Rh(acac)(CO)2] 
2.6 % (S,S)-Ph-BPE 28
[c] 71:29 79 (S)
(6)
0.8% [RhCl(COD)]2 
0.9% (S,S)-Ph-BPE
2.1 % [Rh(acac)(CO)2]
2.6 % (Rax,R,R)-2 67
[c] 74:26 81(R)
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In 2017, we published work describing a tandem 
hydroformylation-cyclisation reaction of allylglycine 
derivatives[16] to either hemi-aminal or hemi-acetals; 
the products could be converted to intermediates for 
the synthesis of an intermediate to the antibiotic, 
Nemonoxacin.[17] The AHF of (S)-allylglycinol, 25, 
using a Rh / (R,R,R)-2 catalyst at 5 bar syngas 
pressure achieves high conversion and selectivity 
(>99% conversion to products, b:l = 4.9:1, d.r = 93:7) 
(Table 4, entry 1). The original ATHF conditions 
using the [Rh]/Ph-BPE catalyst were tested for 
comparison. Standard ATHF conditions using 
[Rh]/Ph-BPE gave a b:l of just 60:40 (Table 4, entry 
2). The dual catalyst procedure, as described in Table 
3, entry 2, with (R,R,R)-2 as the hydroformylation 
component of the catalyst gave 91% consumption of 
the starting material to obtain 75% hemiacetal, 26 and 
16% linear aldehyde, 27 (i.e. a B:L of 82:18, Table 4, 
entry 3). With an effective b:l of 4.7:1, this is 
comparable to the results achieved in AHF (4.9:1). 
However, there was a slight decrease in 
diastereoselectivity, (d.r = 86:14, determined from 1H 
NMR after oxidation to the lactone using 
Ag2CO3/Celite). The results from table 3 and 4 
illustrate that a dual catalyst system derived from 
ligands 1 and 2 is clearly potentially useful. None-
the-less, conversion and selectivity was slightly 
below that observed for AHF using Rh / (R,R,R)-2. 
This may be due to the partial decomposition of 
ligand 2 under the harsher conditions of the activation 
(120 °C for 30 minutes).  
 
Table 4. AHF and ATHF of (S)-allyl glycinol.  
 
We extended the dual catalyst methodology to two 
other catalysts. For example, we felt a catalyst system 
of [Rh(acac)(CO)2]/Bisdiazaphos, 4-[Rh(cod)Cl]2/Ph-
BPE would be particularly advantageous for the 
hydroformylation of alkene 15, as a catalyst derived 
from ligand 4 produced higher regioselectivity to the 
desired isomer for the synthesis of (S)-equol. A 
similar dual catalyst protocol as described in Table 3, 
entry 2 was used, although the reaction was carried 
out at 70 °C for 16 hours; this achieved high 
conversion to the aldehydes (81%), excellent 
enantioselectivity (96% for the major, 23, 92% for 
the minor, 24) and retained the better regioselectivity 
to the desired regioisomer (75:25) (Scheme 3, right). 
This methodology also benefitted another of the cis-
stilbene derivatives, 14, that only obtained low 
conversion (31%) and adequate regioselectivity 
(68:32) in the standard ATHF using 
[Rh(acac)(CO)2]/Ph-BPE. A significant increase in 
conversion to the aldehydes (70%), regioselectivity 
(90:10) and enantioselectivity (96% for the major 
aldehyde, 19) (Scheme 3, left) was achieved after 16 
hours at 70 °C. These results suggest that the 
[Rh]/Bisdiazaphos, 4 catalyst can be used in a 
syngas-free methodology. 
 
[Rh(acac)(CO)2] (2.1 mol%)
(R,S,S)-4 (2.6 mol%)
[Rh(cod)Cl]2 (0.8 mol%)
(S,S)-Ph-BPE (0.9 mol%)
+Ar
2
OMe
Ar2
MeO
CHO
*
Ar2
MeO
*
OHC
OMe
OMeAr2 =
14
 19 
or 23
20 
or 24
O
MeO
[CH2O]n (5 eq.), toluene
120 °C (0.5h), 70 °C, (16 h)
81% aldehydes,[a,c] 
23: 24 = 75:25; 
e.e. of 23 = 96%
e.e. of 24 = 92%
Ar2 =
15
70% aldehydes,[a, b] 
19: 20 = 90:10; 
e.e. of 19 = 96%
e.e. of 20 = n.d.
14 
or 15
[a] Remaining mass balance is predominantly E-alkene and some alkane. 
[b] A yield of 50% for alcohol formed after hydroformylation and NaBH4 
reduction.
[c] A yield of 52% for alcohol formed after hydroformylation and NaBH4 
reduction.  
Scheme 3. ATHF of cis-stilbenes 15 and 16 using a dual 
catalyst system.  
 
 
We also investigated another catalyst in this dual 
catalyst methodology: [Rh]/Kelliphite,[18] which has 
previously obtained very selective results in the AHF 
of Boc-lactam 28 (>99% conv, 29:30 = 7.5:1 (50 °C, 
1 h), or 9.4:1 (15 °C, 16 h).[19] This substrate was also 
investigated in 2015 using the standard ATHF 
reaction using [Rh]/Ph-BPE, and although a full 
conversion was observed in only 5 minutes, it is at 
the expense of a lower selectivity (>99% conversion, 
b:l =2.5:1 on purification).  
Conducting the reaction using the dual catalyst 
protocol with delayed mixing of alkene introduced 
[Rh(acac)(CO)2]
Ligand
N
Bn
Bn OH
N
Bn Bn
O
N
Bn
Bn
(CH2)3CHO
OH
OH
+CO/H2 or [CH2O]n
25 2726
Entry 1:  [b]
0.4 mol% [Rh(acac)(CO)2], 
2 mol% (R,R,R)-2
40 oC, 5 bar syngas, 16h
Procedure Conversion b: l d.r.[a]
>99 83:17 93:7
Entry 2:  
2 mol% [Rh(acac)(CO)2],
3 mol% (S,S)-Ph-BPE
120 oC, 6 equiv. (CH2O)n, 1 h
>99 60:40 85:15
Entry 3:  [c]
2.1 mol% [Rh(acac)(CO)2],
2.6 mol% (R,R,R)-2
0.8 mol% [RhCl(cod)]2
0.9 mol% (S,S)-Ph-BPE
6 equiv. (CH2O)n, 
120 oC (0.5 h), 40 oC 16h
91 82:18 86:14
[a] d.r. determined by 1h NMR spectrsocopy on the lactone obtained after 
oxidation with Ag2CO3. 
[b] result reproduced from ref. 16 [c]dual catalyst 
process with delayed mixing of alkene.
(26: 27)
toluene
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earlier, using [Rh(acac)(CO)2]/(R,R)-Kelliphite and 
[Rh(cod)Cl]2/(S,S)-Ph-BPE led to full conversion to 
the aldehydes and high selectivity towards 29 (7.3:1), 
isolating the nearly isomerically pure 29 in 64% yield 
(Scheme 4). This outperforms the results from the 
standard ATHF reaction and is comparable to those 
achieved using AHF.  
+
>99% conversion, 29:30 = 7.3:1
64% yield (13.3:1) on purification)
NBoc
O
NBoc
O
OHC
NBoc
O
OHC
28
29
[Rh(acac)(CO)2] (2.1 mol%)
(R,R)-Kelliphite (2.6 mol%)
[RhCl(cod)]2 (0.8 mol%)
(S,S)-Ph-BPE (0.9 mol%)
[CH2O]n (5 eq.), toluene
(i) 120 °C (0.5h),  
(ii) 40 °C (16 h)
30
 
Scheme 4. ATHF of a bicyclic lactam using a dual catalyst 
system. 
Conclusion 
In this paper, we have studied the performance of the 
Rh / Ph-BPE catalyst in formal asymmetric transfer 
hydroformylations in greater detail. High 
enantioselectivity can be realised in the ATHF of cis-
stilbene derivatives, but sometimes yields or 
regioselectivity are not optimal. In order to allow a 
broader range of ligands to be used in ATHF, a dual 
catalyst system was developed. In this dual catalyst 
protocol we have used enantiopure Ph-BPE ligands in 
combination with [RhCl(COD)]2 to decompose 
paraformaldehyde into CO and hydrogen. The use of 
a single enantiomer here is purely since such ligands 
are available commercially, although the racemic 
analogues could undoubtedly be used. Using the dual 
catalyst system, the hydroformylation activity comes 
entirely from the ligand pre-mixed with 
[Rh(acac)(CO)2], and hence in the best cases, 
regioselectivity, e.e. or d.r. levels are significantly 
higher than what could be realised using the original 
ATHF protocol for a range of substrates identified as 
problematic. It is hoped this not only provides some 
syngas-free protocols for the specific targets 
described, but is enabling for other workers who may 
wish to use syngas-free hydroformylations. 
Experimental Section 
CAUTION: We have never had any incidents with 
vials cracking due to excess pressure. In experiments 
carried out where pressure was measured in smaller 
10 mL vessels, but using similar amount of 
formaldehyde, the largest pressure measured was 7 
bar (observed in an example where no 
hydroformylation occurred to use up the gas). 
However, the pressure will be proportional to the 
volume of the vessel and the amounts of 
formaldehyde used, so any deviations from this 
protocol should be carried out in a vessel that can 
withstand the pressures encountered. A sealable tube 
(8 bar max pressure, 25 mL) was charged with a 8 
mm cross stirrer bar, paraformaldehyde (126 mg, 5 
eq.) and another small sample vial containing a flea 
stirrer bar. The vial was capped with a rubber septum 
and placed under three vacuum/Ar cycles. A solution 
of the alkene  (0.84 mmol) in toluene (1 mL) and 1-
methylnapthalene (0.05 mL) was made up in a 
Schlenk vial under an inert atmosphere. This was 
transferred into the small sample vial inside the 
sealed tube via syringe. A small sample was and 
analysed by 1H NMR spectroscopy (C6D6) The 
catalyst stock solutions ([Rh(acac)(CO)2] (4.5 mg, 
0.018 mmol, 2.1 mol%)/ligand (e.g. for ligand 2: 14.1 
mg, 0.022 mmol, 2.6 mol%) in toluene (1 mL) and 
[[Rh(cod)Cl]2 (1.7 mg, 0.007 mmol, 0.8 mol%)/Ph-
BPE (3.8 mg, 0.008 mmol, 0.9 mol%) in toluene (1 
mL)) were made up separately in two Schlenk tubes 
under an inert atmosphere. These were transferred to 
the sealed tube (outside of the sample vial) via 
syringe and the rubber septum was placed with a 
fitted cap immediately. The pressure vial was placed 
in an oil bath, and a blast shield was placed in front of 
the reaction. It was then heated to 120 °C for 30 min 
(stirring at speed 1000 rpm), before cooling for 30 
min. (step (ii) in Table 3): The vial was then placed 
back into the oil bath for the desired time at a lower 
temperature before inverting the vial several times (to 
ensure the contents of the smaller vial are fully mixed 
in). This  was left to stir at the desired lower 
temperature for the desired time. The vial was cooled 
to r.t and inverted several times before opening the 
vial. A small sample was taken and analysed by 1H 
NMR spectroscopy (C6D6) to calculate the conversion 
of the resulting aldehydes. The products were 
generally reduced as described in the ESI to deliver 
pure products after chromatography. The 
enantioselectivity of the reaction was determined by 
measuring e.e. on these corresponding primary 
alcohols using chiral HPLC. Full experimental details, 
analytical data, NMR and HPLC spectra can be found 
in the ESI (for compounds not previous 
communicated). Underpinning data (NMR files) are 
also available.[20] 
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FULL PAPER    
CO-free Enantioselective Hydroformylation of 
Functionalised Alkenes: Using a Dual Catalyst 
System to give Improved Selectivity and Yield 
 
R1
R2 CHO
R1
R2
optimised Rh catalyst for 
[CH2O]n decomposition
optimised Rh catalyst for 
asymmetric hydroformylation
[CH2O]n
* high yield
* optimised 
regioselectivity 
* up to 96% e.e.
Two Rh catalysts with different roles are
 compatible with each other, enabling several 
different chiral ligands to be used in CO-free 
hydroformylation
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